47 research outputs found
Correction: Warren et al., Catecholamine-Mediated Increases in Gain Enhance the Precision of Cortical Representations
Testing the effectiveness of a self-efficacy based exercise intervention for inactive people with type 2 diabetes mellitus: design of a controlled clinical trial
<p>Abstract</p> <p>Background</p> <p>Sufficient exercise is important for people with Type 2 Diabetes Mellitus (T2DM), as it can prevent future health problems. Despite, it is estimated that only 30-40% of people with T2DM are sufficiently active. One of the psychosocial constructs that is believed to influence physical activity behaviour, is exercise self-efficacy. The goal of this study is to evaluate a patient-tailored exercise intervention for people with T2DM that takes exercise self-efficacy into account.</p> <p>Methods/Design</p> <p>This study is conducted as a non-randomized controlled clinical trial. Patients are eligible when they are diagnosed with T2DM, exercise less than advised in the ADA guideline of 150 min/week of moderate-intensity aerobic physical activity, have an BMI >25 and are between 18 and 80 years old. Recruitment takes place at a Primary care organization of general practitioners and practice nurses in the south of the Netherlands.</p> <p>Participants are allocated to three groups: An <it>advice intervention</it> -for participants with a high exercise self-efficacy score- in which participants receive a patient-tailored exercise intervention, an <it>intensive intervention</it> -for participants with a low exercise self-efficacy score- in which participants receive a patient-tailored exercise intervention accomplished by a group based intervention, and a <it>control group</it> in which participants receive regular Dutch diabetes care. The primary outcome measure of this study is physical activity. Secondary outcome measures are health status, (symptoms of) depression, exercise self-efficacy, Body Mass Index (BMI), blood pressure and glycemic control.</p> <p>Discussion</p> <p>We aimed to design an intervention that can be implemented in Primary care, but also to design an easy accessible program. This study is innovative as it is -to our best knowledge- the first study that takes level of exercise self-efficacy of people with T2DM into account by means of giving extra support to those with the lowest exercise self-efficacy. If the program succeeds in increasing the amount of physical activity it can be implemented in regular primary care.</p> <p>Trial registration</p> <p>Dutch Trial Register NTR2734</p
Photobiocatalytic chemistry of oxidoreductases using water as the electron donor
[EN] To date, water has been poorly studied as the sacrificial electron donor for biocatalytic redox reactions using isolated enzymes. Here we demonstrate that water can also be turned into a sacrificial electron donor to promote biocatalytic redox reactions. The thermodynamic driving force required for water oxidation is obtained from UV and visible light by means of simple titanium dioxide-based photocatalysts. The electrons liberated in this process are delivered to an oxidoreductase by simple flavin redox mediators. Overall, the feasibility of photobiocatalytic, water-driven bioredox reactions is demonstrated.Financial support from the Spanish Science and Innovation Ministry (Consolider Ingenio 2010-MULTICAT CSD 2009-00050, Subprograma de apoyo a Centros y Universidades de Excelencia Severo Ochoa SEV 2012 0267). M. M. acknowledges the Spanish Science and Innovation Ministry for a 'Juan de la Cierva' postdoctoral contract. S. G. acknowledges the European Union Marie Curie Programme (ITN 'Biotrains', Grant Agreement No. 238531).Mifsud Grau, M.; Gargiulo, S.; Iborra Chornet, S.; Arends, IWCE.; Hollmann, F.; Corma Canós, A. (2014). Photobiocatalytic chemistry of oxidoreductases using water as the electron donor. Nature Communications. 5:1-6. https://doi.org/10.1038/ncomms4145S165Bornscheuer, U. T. et al. Engineering the third wave of biocatalysis. Nature 485, 185–194 (2012).Breuer, M. et al. Industrial methods for the production of optically active intermediates. Angew. Chem. Int. Ed. 43, 788–824 (2004).Pollard, D. J. & Woodley, J. M. Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol. 25, 66–73 (2007).Ran, N., Zhao, L., Chen, Z. & Tao, J. Recent applications of biocatalysis in developing green chemistry for chemical synthesis at the industrial scale. Green. Chem. 10, 361–372 (2008).Schmid, A. et al. Industrial biocatalysis today and tomorrow. Nature 409, 258–268 (2001).Schmid, A., Hollmann, F., Park, J. B. & Bühler, B. The use of enzymes in the chemical industry in Europe. Curr. Opin. Biotechnol. 13, 359–366 (2002).Schoemaker, H. E., Mink, D. & Wubbolts, M. G. Dispelling the myths-biocatalysis in industrial synthesis. Science 299, 1694–1697 (2003).Turner, N. J. & O’Reilly, E. Biocatalytic retrosynthesis. Nat. Chem. Biol. 9, 285–288 (2013).Drauz K., Gröger H., May O. (eds)Enzyme Catalysis in Organic Synthesis Wiley-VCH: Weinheim, (2012).Weckbecker, A., Gröger, H. & Hummel, W. Regeneration of nicotinamide coenzymes: principles and applications for the synthesis of chiral compounds. inBiosystems Engineering I: Creating Superior Biocatalysts pp195–242Springer: Berlin, (2010).Van der Donk, W. A. & Zhao, H. Recent developments in pyridine nucleotide regeneration. Curr. Opin. Biotechnol. 14, 421–426 (2003).Wu, H. et al. Methods for the regeneration of nicotinamide coenzymes. Green. Chem. 15, 1773–1789 (2013).Rodriguez, C., Lavandera, I. & Gotor, V. Recent advances in cofactor regeneration systems applied to biocatalyzed oxidative processes. Curr. Org. Chem. 16, 2525–2541 (2012).Reipa, V., Mayhew, M. P. & Vilker, V. L. A direct electrode-driven P450 cycle for biocatalysis. Proc. Natl Acad. Sci. USA 94, 13554–13558 (1997).Bernard, J., van Heerden, E., Arends, I. W. C. E., Opperman, D. J. & Hollmann, F. Chemoenzymatic reduction of conjugated C=C double bonds. Chem. Cat. Chem. 4, 196–199 (2012).Hollmann, F., Arends, I. W. C. E. & Bühler, K. Biocatalytic redox reactions for organic synthesis: nonconventional regeneration methods. Chem. Cat. Chem. 2, 762–782 (2010).Hollmann, F., Hofstetter, K., Habicher, T., Hauer, B. & Schmid, A. Direct electrochemical regeneration of monooxygenase subunits for biocatalytic asymmetric epoxidation. J. Am. Chem. Soc. 127, 6540–6541 (2005).Hollmann, F., Lin, P.-C., Witholt, B. & Schmid, A. Stereospecific biocatalytic epoxidation: the first example of direct regeneration of a fad-dependent monooxygenase for catalysis. J. Am. Chem. Soc. 125, 8209–8217 (2003).Hollmann, F. & Schmid, A. Towards [Cp*Rh(bpy)(H2O)]2+-promoted P450 catalysis: direct regeneration of CytC. J. Inorg. Biochem. 103, 313–315 (2009).Hollmann, F., Taglieber, A., Schulz, F. & Reetz, M. T. A light-driven stereoselective biocatalytic oxidation. Angew. Chem. Int. Ed. 46, 2903–2906 (2007).Mifsud Grau, M. et al. Photoenzymatic reduction of C=C double bonds. Adv. Synth. Catal. 351, 3279–3286 (2009).Ruinatscha, R., Dusny, C., Buehler, K. & Schmid, A. Productive asymmetric styrene epoxidation based on a next generation electroenzymatic methodology. Adv. Synth. Catal. 351, 2505–2515 (2009).Schwaneberg, U., Appel, D., Schmitt, J. & Schmid, R. D. P450 in biotechnology: zinc driven ω-hydroxylation of p-nitrophenoxydodecanoic acid using P450 BM-3 F87A as a catalyst. J. Biotechnol. 84, 249–257 (2000).Taglieber, A., Schulz, F., Hollmann, F., Rusek, M. & Reetz, M. T. Light-Driven Biocatalytic Oxidation and Reduction Reactions: Scope and Limitations. Chem. Bio. Chem. 9, 565–572 (2008).Udit, A. K., Arnold, F. H. & Gray, H. B. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3. J. Inorg. Biochem. 98, 1547–1550 (2004).Udit, A. K., Hill, M. G., Bittner, V. G., Arnold, F. H. & Gray, H. B. Reduction of dioxygen catalyzed by pyrene-wired heme domain cytochrome p450 bm3 electrodes. J. Am. Chem. Soc. 126, 10218–10219 (2004).Unversucht, S., Hollmann, F., Schmid, A. & van Pée, K.-H. FADH2-Dependence of Tryptophan 7-Halogenase. Adv. Synth. Catal. 347, 1163–1167 (2005).Zilly, F. E., Taglieber, A., Schulz, F., Hollmann, F. & Reetz, M. T. Deazaflavins as mediators in light-driven cytochrome P450 catalyzed hydroxylations. Chem. Commun. 7152–7154 (2009).Yehezkeli, O. et al. Integrated photosystem II-based photo-bioelectrochemical cells. Nat. Commun. 3, 742 (2012).Duan, L. et al. A molecular ruthenium catalyst with water-oxidation activity comparable to that of photosystem II. Nat. Chem. 4, 418–423 (2012).Dau, H., Zaharieva, I. & Haumann, M. Recent developments in research on water oxidation by photosystem II. Curr. Opin. Chem. Biol. 16, 3–10 (2012).Qu, Y. & Duan, X. Progress, challenge and perspective of heterogeneous photocatalysts. Chem. Soc. Rev. 42, 2568–2580 (2013).Takanabe, K. & Domen, K. Preparation of inorganic photocatalytic materials for overall water splitting. Chem. Cat. Chem. 4, 1485–1497 (2012).Wee, T.-L. et al. Photochemical synthesis of a water oxidation catalyst based on cobalt nanostructures. J. Am. Chem. Soc. 133, 16742–16745 (2011).Cargnello, M. & Fornasiero, P. Photocatalysis by nanostructured TiO2 based semiconductors. inHandbook of Green Chemistry, Green Nanoscience (eds Selva M., Perosa A. Wiley-VCH: Weinheim, (2010).Liu, S. Q. & Chen, A. C. Coadsorption of horseradish peroxidase with thionine on TiO2: Nanotubes for biosensing. Langmuir 21, 8409–8413 (2005).Zhang, Y., He, P. L. & Hu, N. F. Horseradish peroxidase immobilized in TiO2 nanoparticle films on pyrolytic graphite electrodes: direct electrochemistry and bioelectrocatalysis. Electrochim. Acta 49, 1981–1988 (2004).Chen, D., Zhang, H., Li, X. & Li, J. H. Biofunctional titania nanotubes for visible-light-activated photoelectrochemical biosensing. Anal. Chem. 82, 2253–2261 (2010).Gomes Silva, C. U., Juárez, R., Marino, T., Molinari, R. & García, H. Influence of excitation wavelength (UV or visible light) on the photocatalytic activity of titania containing gold nanoparticles for the generation of hydrogen or oxygen from water. J. Am. Chem. Soc. 133, 595–602 (2010).Opperman, D. J., Piater, L. A. & van Heerden, E. A novel chromate reductase from Thermus scotoductus SA-01 related to old yellow enzyme. J. Bacteriol. 190, 3076–3082 (2008).Opperman, D. J. et al. Crystal structure of a thermostable old yellow enzyme from Thermus scotoductus SA-01. Biochem. Biophys. Res. Commun. 393, 426–431 (2010).Choi, S. H. et al. The influence of non-stoichiometric species of V/TiO2 catalysts on selective catalytic reduction at low temperature. J. Mol. Catal. A: Chem. 304, 166–173 (2009)
Exploration of Shared Genetic Architecture Between Subcortical Brain Volumes and Anorexia Nervosa
In MRI scans of patients with anorexia nervosa (AN), reductions in brain volume are often apparent. However, it is unknown whether such brain abnormalities are influenced by genetic determinants that partially overlap with those underlying AN. Here, we used a battery of methods (LD score regression, genetic risk scores, sign test, SNP effect concordance analysis, and Mendelian randomization) to investigate the genetic covariation between subcortical brain volumes and risk for AN based on summary measures retrieved from genome-wide association studies of regional brain volumes (ENIGMA consortium, n = 13,170) and genetic risk for AN (PGC-ED consortium, n = 14,477). Genetic correlations ranged from − 0.10 to 0.23 (all p > 0.05). There were some signs of an inverse concordance between greater thalamus volume and risk for AN (permuted p = 0.009, 95% CI: [0.005, 0.017]). A genetic variant in the vicinity of ZW10, a gene involved in cell division, and neurotransmitter and immune system relevant genes, in particular DRD2, was significantly associated with AN only after conditioning on its association with caudate volume (pFDR = 0.025). Another genetic variant linked to LRRC4C, important in axonal and synaptic development, reached significance after conditioning on hippocampal volume (pFDR = 0.021). In this comprehensive set of analyses and based on the largest available sample sizes to date, there was weak evidence for associations between risk for AN and risk for abnormal subcortical brain volumes at a global level (that is, common variant genetic architecture), but suggestive evidence for effects of single genetic markers. Highly powered multimodal brain- and disorder-related genome-wide studies are needed to further dissect the shared genetic influences on brain structure and risk for AN
Association analysis between a VNTR intron 8 polymorphism of the dopamine transporter gene (SLC6A3) and obsessive- compulsive disorder in a Brazilian sample
The PICO project: aquatic exercise for knee osteoarthritis in overweight and obese individuals
A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)
Meeting abstrac